These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
351 related articles for article (PubMed ID: 24005989)
21. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma. Xia L; Huang W; Tian D; Zhu H; Zhang Y; Hu H; Fan D; Nie Y; Wu K J Hepatol; 2012 Sep; 57(3):600-12. PubMed ID: 22613004 [TBL] [Abstract][Full Text] [Related]
22. IL-1β-Induced Elevation of Solute Carrier Family 7 Member 11 Promotes Hepatocellular Carcinoma Metastasis Through Up-regulating Programmed Death Ligand 1 and Colony-Stimulating Factor 1. He Q; Liu M; Huang W; Chen X; Zhang B; Zhang T; Wang Y; Liu D; Xie M; Ji X; Sun M; Tian D; Xia L Hepatology; 2021 Dec; 74(6):3174-3193. PubMed ID: 34288020 [TBL] [Abstract][Full Text] [Related]
23. PRRX1 deficiency induces mesenchymal-epithelial transition through PITX2/miR-200-dependent SLUG/CTNNB1 regulation in hepatocellular carcinoma. Chen W; Wu J; Shi W; Zhang G; Chen X; Ji A; Wang Z; Wu J; Jiang C Cancer Sci; 2021 Jun; 112(6):2158-2172. PubMed ID: 33587761 [TBL] [Abstract][Full Text] [Related]
24. ETS1 is coexpressed with ZEB2 and mediates ZEB2-induced epithelial-mesenchymal transition in human tumors. Yalim-Camci I; Balcik-Ercin P; Cetin M; Odabas G; Tokay N; Sayan AE; Yagci T Mol Carcinog; 2019 Jun; 58(6):1068-1081. PubMed ID: 30790340 [TBL] [Abstract][Full Text] [Related]
25. FOXC1 promotes HCC proliferation and metastasis by Upregulating DNMT3B to induce DNA Hypermethylation of CTH promoter. Lin Z; Huang W; He Q; Li D; Wang Z; Feng Y; Liu D; Zhang T; Wang Y; Xie M; Ji X; Sun M; Tian D; Xia L J Exp Clin Cancer Res; 2021 Feb; 40(1):50. PubMed ID: 33522955 [TBL] [Abstract][Full Text] [Related]
27. MiR-141 targets ZEB2 to suppress HCC progression. Wu SM; Ai HW; Zhang DY; Han XQ; Pan Q; Luo FL; Zhang XL Tumour Biol; 2014 Oct; 35(10):9993-7. PubMed ID: 25008569 [TBL] [Abstract][Full Text] [Related]
28. miR-154 targeting ZEB2 in hepatocellular carcinoma functions as a potential tumor suppressor. Pang X; Huang K; Zhang Q; Zhang Y; Niu J Oncol Rep; 2015 Dec; 34(6):3272-9. PubMed ID: 26503460 [TBL] [Abstract][Full Text] [Related]
29. FOXQ1 promotes gastric cancer metastasis through upregulation of Snail. Zhang J; Liu Y; Zhang J; Cui X; Li G; Wang J; Ren H; Zhang Y Oncol Rep; 2016 Jun; 35(6):3607-13. PubMed ID: 27109028 [TBL] [Abstract][Full Text] [Related]
30. [Hepatocellular Carcinoma Cells with Downregulated ZEB2 Become Resistant to Resveratrol by Concomitant Induction of ABCG2 Expression]. Balcik-Ercin P; Cetin M; Yalim-Camci I; Uygur T; Yagci T Mol Biol (Mosk); 2020; 54(1):87-94. PubMed ID: 32163392 [TBL] [Abstract][Full Text] [Related]
31. Promotion of epithelial-mesenchymal transformation by hepatocellular carcinoma-educated macrophages through Wnt2b/β-catenin/c-Myc signaling and reprogramming glycolysis. Jiang Y; Han Q; Zhao H; Zhang J J Exp Clin Cancer Res; 2021 Jan; 40(1):13. PubMed ID: 33407720 [TBL] [Abstract][Full Text] [Related]
32. Regulatory role of miR-211-5p in hepatocellular carcinoma metastasis by targeting ZEB2. Jiang G; Wen L; Deng W; Jian Z; Zheng H Biomed Pharmacother; 2017 Jun; 90():806-812. PubMed ID: 28437884 [TBL] [Abstract][Full Text] [Related]
33. Overexpression of ZEB2 in peritumoral liver tissue correlates with favorable survival after curative resection of hepatocellular carcinoma. Cai MY; Luo RZ; Chen JW; Pei XQ; Lu JB; Hou JH; Yun JP PLoS One; 2012; 7(2):e32838. PubMed ID: 22393452 [TBL] [Abstract][Full Text] [Related]
34. 14-3-3ε overexpression contributes to epithelial-mesenchymal transition of hepatocellular carcinoma. Liu TA; Jan YJ; Ko BS; Liang SM; Chen SC; Wang J; Hsu C; Wu YM; Liou JY PLoS One; 2013; 8(3):e57968. PubMed ID: 23483955 [TBL] [Abstract][Full Text] [Related]
35. Targeting FoxM1 inhibits proliferation, invasion and migration of nasopharyngeal carcinoma through the epithelial‑to-mesenchymal transition pathway. Yu C; Chen L; Yie L; Wei L; Wen T; Liu Y; Chen H Oncol Rep; 2015 May; 33(5):2402-10. PubMed ID: 25738652 [TBL] [Abstract][Full Text] [Related]
36. ZEB2 promotes the metastasis of gastric cancer and modulates epithelial mesenchymal transition of gastric cancer cells. Dai YH; Tang YP; Zhu HY; Lv L; Chu Y; Zhou YQ; Huo JR Dig Dis Sci; 2012 May; 57(5):1253-60. PubMed ID: 22350782 [TBL] [Abstract][Full Text] [Related]
37. Metadherin promotes hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition. Zhu K; Dai Z; Pan Q; Wang Z; Yang GH; Yu L; Ding ZB; Shi GM; Ke AW; Yang XR; Tao ZH; Zhao YM; Qin Y; Zeng HY; Tang ZY; Fan J; Zhou J Clin Cancer Res; 2011 Dec; 17(23):7294-302. PubMed ID: 21976539 [TBL] [Abstract][Full Text] [Related]
38. HEG1 indicates poor prognosis and promotes hepatocellular carcinoma invasion, metastasis, and EMT by activating Wnt/β-catenin signaling. Zhao YR; Wang JL; Xu C; Li YM; Sun B; Yang LY Clin Sci (Lond); 2019 Jul; 133(14):1645-1662. PubMed ID: 31278131 [TBL] [Abstract][Full Text] [Related]
39. HOXD9 promotes epithelial-mesenchymal transition and cancer metastasis by ZEB1 regulation in hepatocellular carcinoma. Lv X; Li L; Lv L; Qu X; Jin S; Li K; Deng X; Cheng L; He H; Dong L J Exp Clin Cancer Res; 2015 Oct; 34():133. PubMed ID: 26514226 [TBL] [Abstract][Full Text] [Related]
40. ACP5, a direct transcriptional target of FoxM1, promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma. Xia L; Huang W; Tian D; Chen Z; Zhang L; Li Y; Hu H; Liu J; Chen Z; Tang G; Dou J; Sha S; Xu B; Liu C; Ma J; Zhang S; Li M; Fan D; Nie Y; Wu K Oncogene; 2014 Mar; 33(11):1395-406. PubMed ID: 23604121 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]